- Alteogen has signed a new technology export contract with a pharmaceutical company.
- ALT-B4 can replace intravenous drugs with subcutaneous drugs.
- ALT-B4 is a human hyaluronidase technology.
South Korean bio company Alteogen has secured a new technology export contract with an unnamed global pharmaceutical company. This contract is for technology export regard....
Tags : Alteogen, ALT-B4, Hyaluronidases,